
Sign up to save your podcasts
Or
Introducing HIV: Racing to Identify a Killer from Incubation.
Follow the show: Incubation
After four decades of dedicated research on HIV, scientists have made extraordinary progress in treating the disease. But we still don’t have a vaccine or a cure. On today’s show, we’re joined by two veteran scientists who have dedicated their careers to HIV research. First up is Christine Rouzioux, a virologist from the Nobel Prize winning team of scientists who first identified the HIV virus. For the second half of the show we talk with Richard Koup from the National Institutes of Health, who explains why it’s so hard to create an HIV vaccine.
See omnystudio.com/listener for privacy information.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
4.7
783783 ratings
Introducing HIV: Racing to Identify a Killer from Incubation.
Follow the show: Incubation
After four decades of dedicated research on HIV, scientists have made extraordinary progress in treating the disease. But we still don’t have a vaccine or a cure. On today’s show, we’re joined by two veteran scientists who have dedicated their careers to HIV research. First up is Christine Rouzioux, a virologist from the Nobel Prize winning team of scientists who first identified the HIV virus. For the second half of the show we talk with Richard Koup from the National Institutes of Health, who explains why it’s so hard to create an HIV vaccine.
See omnystudio.com/listener for privacy information.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
69,438 Listeners
9,048 Listeners
10,260 Listeners
12,644 Listeners
58,176 Listeners
2,554 Listeners
3,829 Listeners
1,041 Listeners
4,085 Listeners
10,736 Listeners
2,829 Listeners
983 Listeners
3,566 Listeners
1,380 Listeners
9,287 Listeners